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ABSTRACT
Cell morphological changes are normally considered as the indirect evidence of the effect of test materials on targeted
cells. In this study, the effects of nerolidol (C12H26O) and allicin (C3H5SS(O)C3H5), extracted from cardamon (Eiettaria
cardamomum) and garlic (Allium sativum) respectively, were compared with the effect of berenil (standard anti-trypanosomal
drug) on the morphological changes of a protozoan parasite Trypanosoma evansi in mice, determined by light microscope
and electron microscopy. Groups of male ICR mice strain were subjected to infection with and without the parasite
trypanomastigote (5.0 × 103 T. evansi per mouse), treated with nerolidol and allicin, and treated with berenil or distilled
water as the control. Blood samples were collected and prepared both for the observation under light and electron
microscopes. Parasites observed at the trypomastogote stage had adverse morphological changes due to berenil treatment
and after the 2nd – 3rd hour post-treatment, the parasites became stiffened and tapered at both ends and distorted with fractured
flagella and loss of undulating membranes before totally disintegrated and cleared from the blood at the 6th – 7th hour
post-treatment. The morphological changes in the nerolidol-treated group only appeared after the 23rd day post-treatment
and continued gradually until the 25th day post-treatment when the parasites became stiff, lost their undulating membrane
but the free flagella remained intact. Total disfigurement was only observed at the 27th day post-treatment. On the other
hand, parasites in the allicin-treated group also showed marked morphological changes, although not as profound as changes
due to berenil. Changes started to occur only after the 18th day post treatment, and gradually intensified up until the 90th
day post treatment although the treatments were terminated on day 30th. The parasite also became crescent in shape and
lost their undulating membranes and cytoplasm where total disfigurement was only observed in the 95th days post-infection.
All mice in the negative group (untreated-infected) succumbed to infection with drastic increase of parasitaemia while all
the infected and berenil-treated mice survived the infections for more than 100 days post-infection. These observations
indicate that, to a certain extent, nerolidol and allicin showed convincing and promising anti-trypanosomatidal activity
against the morphology of T. evansi in mice. Further studies are required to elucidate the mechanism(s) of action of these
compounds.
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INTRODUCTION
Trypanosoma evansi is the parasite that can cause
trypanosomiasis or surra disease to most of the
mammals such as goat, pig, camel, cow and donkey
(Ventura et al., 2000). Its wide range and chronic
type of infections were believed to have affected the
productivity of livestock especially in country where
veterinary sectors play a major role as economic
resources (Yabu, 1998). It was originally discovered
in horses and camels by Griffith Evans in Punjab
India and in Malaysia, it was first recorded in
buffaloes, goats and dogs in 1903 (Zainal-Abidin,
1992). Nerolidol or 3,7,11-trimethyl-1,6,10-
dodecatrien-3-ol (C12H26O) is an active compound
that naturally occurs in oil form in cardamom seed,
Eiettaria cardamomum. In South Asia, cardamom is
widely used to treat infections in teeth, to prevent
and treat sore throat, congestion of the lungs and
pulmonary tuberculosis, inflammation of eyelids and
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also to treat digestive disorders (Ravindran, 2002).
It was in vitro proven that nerolidol was able to
inhibit the growth of promastigotes stage of
Leishmania amazonensis, L. braziliensis and L.
chagasi as well on the amastigotes stage of L.
amazonensis with its 50 % inhibitory concentrations
(IC50) were 85 μM, 74 μM, 75 μM and 67 μM,
respectively (Denise et al., 2004). While, allicin or
diallyl thiosulfinate (C3H5SS(O)C3H5), is the main
biologically active compound derived from garlic,
Allium sativum that has been used as a general food
and a remedy for a long time. It was found that
Entamoeba histolytica was very sensitive to allicin,
and at 30 g/ml, allicin totally inhibited the growth
of amoeba cultures (Ankri et al., 1997). Allicin (30
μg/ml) was also very efficient to inhibit the growth
of other protozoan parasites such as Giardia lamblia,
Leishmania major, Leptomonas colosoma and
Crithidia fasciculate (Rabinkov et al., 1998). The
present study was carried out to determine the anti-
trypanosomal effects of nerolidol and allicin on the
morphology of T. evansi in mice, determined via
both light and electron microscopes.
MATERIALS AND METHODS
Male ICR mice strain (Mus musculus) aged 6 – 8
weeks and 20 – 25 g body weights were used to
maintain T. evansi stock and as experimental mice.
All groups for treatment and control consisted of six
mice per group and the inoculum used was 5.0 × 103
T. evansi per mouse and administrated
intraperitoneally. The blood slides were prepared
from mice tail bleeding and stained with Giemsa’s.
These slides were used to determine pre-patent
period and peak parasitaemias of the infected mice.
Granules form of commercial anti-trypanosomal
drug, berenil, from Hoechst Ag brand was obtained
from Sigma-Aldrich (Germany). Every 2.36 g of the
berenil granules contained 1.05 g 4,4’-diamidino
diazoaminobenzine diaceturate. As described by
Talakal et al. (2000), 3.5 mg/kg body weight is the
best reservoir value of berenil for experimental mice.
The granules were solubilised in 12.5 mL sterile
dH2O as documented by Verma et al. (1976). While
nerolidol (contained the mixture of ±40% of cis-
3,7,11-trimethyl-1,6,10-dodecatrien-3-ol and ±55%
of trans-3,7,11-trimethyl-1,6,10-dodecatrien-3-ol)
was obtained from Merck (Germany). Every liter of
the solution contained 880 g of nerolidol substance
and at the concentration of 222.37 g/mol, the stock
of nerolidol solution were prepared as described by
Denise et al, (2004). Allium sativum in tablet form
(Natural Factors Garlic, Canada) were used as the
source for allicin treatment. Every tablet of 500 mg
contained 750 μg allicin (C3H5S2OC3H5) where this
amount is similar as much as contained in 1500 mg
of fresh garlic. Using two tablets from Natural
Factors Garlic, an amount of 15 μg/ mL of allicin
solution stock were prepared according to Ankri et
al, (1997). Next, the dose at 0.1 ml of 8.8 μg/ml
nerolidol solutions was given intraperitoneally while
0.1 ml of 15 μg/ml allicin solution was given orally
to groups of mice according to the following regimes
and groups: two negative and one positive control
groups, three groups of pre-infection treatment (1
day, 3 days and 5 days before infection), one
concurrent treatment group (5 minutes right after
infection) and one post-infection treatment group (3
days after infection). The negative control groups
either received 0.1 ml distilled water orally or lethal
infection with 5.0 × 103 T. evansi per mouse given
intraperitoneally without any treatment. Berenil at
0.01 ml of 3.5 mg/kg body weight was administrated
into positive control mice which previously received
T. evansi infection at 7 days before treatment. Blood
samples were collected subsequently following the
treatments and used to prepare for both the normal
observations under light microscope using Leica
CME model completed with Canon LA-DC58F
digital camera and also for electron microscopy
using Phillips XL30 and Leo 1450VP microscope.
By using MINITAB version 16, the mean difference
of parasitaemia level (%), survival time (day) and
pre-patent time (day) of the mice were also
determined by ANOVA test at p<0.05 significant
level.
RESULTS AND DISCUSSION
Generally, the results in Fig. 1, 2, 3 and 4 summarize
the morphological changes of T. evansi in all groups
of the experimental and berenil-treated mice. Beside
these, the results also showed there were differences
in survival times of all groups of the experimental
mice which vary according to the test compounds
used. As showed in Table 1 and Table 2, the results
indicated that the earlier the test materials given
before infection, the longer the pre-patent period
observed and also the longer the mice survived.
Overall, the allicin-treated group showed more
convincing results, particularly for the KRA(a)
group where interestingly, the mice survived up to
more than 90 days post-treatment if treatment were
given daily starting 7 days before infection and
terminating at 30 days post infection. For all groups,
the results showed that the treated-group mice
always had higher peak of parasitaemias as
compared to that of the peak parasitaemias in the
control mice (p<0.05).
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Table 1 : Vital parameters observed from experimental mice in nerolidol-treated group.
              GROUP PARAMETERS
             Nature of infection
Subgroup Group                 and treatment Peak Pre-patent Survival
Name Parasitaemia (%)* Period (days)* Time (days)*
Negative KKN(a) T. evansi only without treatment 38.67 ± 0.5 4.56 ± 0.3 8.41 ± 0.3
control
KKN(b) Daily dose - dH2O given started 38.98 ± 0.2 5.47 ± 0.3 9.23 ± 0.2
at 7 days post-infection
Positive KKP(a) Single dose - Berenil given 18.79 ± 2.0 4.38 ± 0.2 > 100
control 7 days after
Treatment KRN(a) Daily dose - Started at 5 days 43.59 ± 1.2 21.48 ± 0.2 28.58 ± 0.2
with pre-infection
nerolidol
(**) KRN(b) Daily dose - Started at 3 days 43.38 ± 1.7 15.42 ± 0.2 22.48 ± 0.2
pre-infection
KRN(c) Daily dose - Started at 1 day 47.45 ± 1.6 8.45 ± 0.4 15.60 ± 0.2
pre-infection
KRN(d) Daily dose - Started 5 minutes 43.77 ± 1.2 6.61 ± 0.2 13.65 ± 0.1
after infection
KRN(e) Daily dose - Started 3 days 36.02 ± 2.6 3.52 ± 0.2 8.54 ± 0.2
post-infection
(*) Mean ± S.D.
(**) All daily dose given until the mice died or up to 30 days post infection.
Table 2 : Vital parameters observed from experimental mice in allicin-treated group.
              GROUP PARAMETERS
             Nature of infection
Subgroup Group                 and treatment Peak Pre-patent Survival
Name Parasitaemia (%)* Period (days)* Time (days)*
Negative KKN(c) T. evansi only without treatment 38.35 ± 1.7 4.56 ± 0.2 9.36 ± 0.1
control
KKN(d) Daily dose - dH2O given started 39.74 ± 0.4 4.22 ± 0.1 9.11 ± 0.3
at 7 days post-infection
Positive KKP(b) Single dose - Berenil given 7 19.83 ± 1.2 4.56 ± 0.3 > 100
control days after
Treatment KRA(a) Daily dose - Started at 7 days 47.09 ± 0.2 20.42 ± 0.3 96.58 ± 0.2
with allicin pre-infection
(**)
KRA(a) Daily dose - Started at 5 days 42.81 ± 1.2 82.54 ± 0.2 91.67 ± 0.4
pre-infection
KRA(a) Daily dose - Started at 3 days 46.24 ± 1.1 77.42 ± 0.2 86.48 ± 0.2
pre-infection
KRA(a) Daily dose - Started at 1 day 42.51 ± 1.7 74.5 ± 0.2 83.43 ± 0.2
pre-infection
KRA(a) Daily dose - Started 5 minutes 47.01 ± 2.3 8.60 ± 0.2 16.64 ± 0.3
after infection
KRA(a) Daily dose - Started 3 days 36.02 ± 2.6 3.52 ± 0.2 8.54 ± 0.2
post-infection
(*) Mean ± S.D.
(**) All daily dose given until the mice died or up to 30 days post infection.
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Fig. 1.  The decrease of the parasite population and the morphological changes of T. evansi observed in light
(×100 magnification) and electron (SEM at ×4000 – ×5000 magnification) microscope as appeared in nerolidol-
treated mice blood from KRN(a) group, starting from 23 days post-treatment (a) and (d), 2 days after its pre-
patent period and its continued gradually at 25 days post-treatment (b) and (e), where the parasites became
stiff (X), lost their undulating membrane (Y) but the free flagella remained intact (Z) and at 27 days  post-
treatment (c) and (f) where total disfigurement (P) can be observed, but somehow it was too late to save the
mice.
Fig. 1 shows the observation taken from the
mice in group KRN(a). The pictures obviously
revealed the  normal morphology of T. evansi in the
nerolidol-treated group as appeared after the 23rd day
post-treatment, which gradually changed until the
25th day post-treatment where the parasites became
stiff, lost their undulating membrane but still free
flagellum remained intact. Total disfigurement was
only observed at the 27th day post-treatment but it
was too late to save the mice. This phenomenon can
be related with an earlier report by Ogunlana et al.
(1987) that stressed the ability of nerolidol to inhibit
the synthesis of peptidoglycan molecule which is
critically needed in constructing the parasite single
cell bi-layer cell membrane such as T. evansi.
Likewise, using E. coli as a model, Turi et al. (1997)
also found that the capability of nerolidol to modify
the hydrophobic characteristic on the surface of cell
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Fig. 2.  The decrease of the parasite population and the morphological changes of T. evansi observed in light
(×100 magnification) and electron (SEM at ×4000 – ×5000 magnification) microscope as appeared in allicin-
treated mice blood from KRA(a) group at 30 days post-treatment (a) and (d) where allicin treatments were
terminated on this day, and at 60 days later (b) and (e) where the parasites became more crescent in shape (X)
and lost most of the undulating membranes (Y) and cytoplasm (Z) and at 93 days  post-treatment (c) and (f),
where total disfigurement (P) of some parasites was observed.
membrane might lead to the higher possibility of
changing the original structure or morphology of
cells in general.
Although parasites in the allicin-treated mice
also showed some obvious morphological changes
but the action was slow, unpredictable and not as
drastic as that under berenil treatment. Gadually, the
morphological changes only started to appear after
about 18 days post-treatment and continued
gradually up to the 90th day post treatment although
30 days the treatment was terminated after infection.
The pictures in Fig.2 were taken from the mice in
group KRA(a) where the parasites became more
crescent in shape and lost most of the undulating
membranes and cytoplasm. However, on the 94th
day, the normal parasites reappeared in the blood
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Fig. 3. (a) The mixture of normal shaped T. evansi (in circle) with crescent-shaped T. evansi (in square) in
allicin-treated mice from KRA(a) group on day 94th post-treatment as observed in light microscope (×100
magnification) and (b) the mixture of normal morphology of T. evansi (in circle) with crescent-shape T. evansi
(in square) as observed in electron microscope (SEM at ×1660 magnification).
and maintained in the circulation together with the
morphologically-changed T. evansi (Fig. 3) that may
have caused the death of the mice in this group on
day 96th. The anti-tripanosomal activities of allicin
revealed in this study supports the earlier result that,
allicin at 30 μg/ml very efficiently inhibited the
growth of other protozoan parasites such as
Leishmania major (Rabinkov et al., 1998), the
parasite belonging to the same phylum with
Trypanosoma. Supporting this documentation, allicin
and the condensation product of allicin, ajoene,
which has a similar oxygenated sulfur group, has
been shown to inhibit the proliferation of
Trypanosoma sp., possibly by inhibition of
phosphatidylcholine biosynthesis (Yabu et al.,
1998).
Morphological changes that occurred in T.
evansi in berenil-treated mice appeared as soon as
2 – 3 hours post-treatment as shown in Fig. 4, where
the parasites become stiffened and tapered at both
ends. The most massive changes such as the loss of
undulating membrane and fractured flagella
appeared 4 hours post-treatment. By 5 – 6 hours
post-treatment the parasites were totally squashed
and disintegrated and cleared from the blood
circulation. This observation happened in both the
positive control of experimental mice, KKP(a), in
nerolidol-treated group and KKP(b), in allicin-
treated group. As a standard and the best drug in
treating trypanosomiasis (Talakal et al., 2000), the
reason behind this finding is because berenil directly
interacts by binding the parasite DNA at the A-T rich
region (Clausen et al., 1999), thus leading to the
formation of hydrogen bonds whereby the vital DNA
processes such as transcription and replication may
be inhibited (Brown et al., 1992).
The overall results of this study suggest that
although the test materials studied were less effective
to clear T. evansi from the blood circulation, the
results imply that these bioactive compounds may
have some anti-trypanosomatidal activities. These
compounds might have acted sufficiently by slowing
down or inhibiting the progress of the infection as
to allow the mice to survive much longer. Thus, it
is highly recommended that a further study is
required to determine the gross effects of these
bioactive compounds, particularly allicin, on the
morphology of the parasite, as a proof of its action
in this study. This is also suggested in order to
elucidate the clear mechanism(s) of action of these
compounds on the development of T. evansi.
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Fig. 4.  The decrease of the parasite population and the morphological changes of T. evansi observed in light
(×100 magnification) and electron (SEM at ×3000 – ×5000 magnification) microscope as appeared in berenil-
treated mice blood (positive control) starting from 1 hour post-treatment (a) and (d), 3 hours  post-treatment
(b) and (e), where the most massive changes such as the loss of undulating membrane (X) and fractured flagella
(Y) appeared, and 6 hours  post-treatment (c) and (f), where the parasites were totally disintegrated (Z) and
cleared from the blood circulation.
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